0001493152-21-016652.txt : 20210712 0001493152-21-016652.hdr.sgml : 20210712 20210712171131 ACCESSION NUMBER: 0001493152-21-016652 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210712 DATE AS OF CHANGE: 20210712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gupta Pramod CENTRAL INDEX KEY: 0001857927 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 211086148 MAIL ADDRESS: STREET 1: UNICYCIVE THERAPEUTICS, INC. STREET 2: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 3 1 ownership.xml X0206 3 2021-07-12 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001857927 Gupta Pramod C/O UNICYCIVE THERAPEUTICS, INC. 5150 EL CAMINO REAL SUITE A-32 LOS ALTOS CA 94022 0 1 0 0 EVP, Pharma and Business Ops Employee Stock Option (right to buy) 3.27 2029-10-01 Common Stock 52326 D Employee Stock Option (right to buy) 3.27 2029-12-30 Common Stock 23256 D Employee Stock Option (right to buy) 3.27 2030-04-06 Common Stock 58140 D Employee Stock Option (right to buy) 7.01 2031-03-01 Common Stock 23256 D Twenty-five percent (25%) of the stock options vested on October 1, 2020, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on October 1, 2023. Twenty-five percent (25%) of the stock options vested on January 1, 2021, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on January 1, 2024. Twenty-five percent (25%) of the stock options vested on April 6, 2021, and the remaining seventy-five percent (75%) of the stock options have vested and will continue to vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on April 6, 2024. Twenty-five percent (25%) of the stock options vest on March 1, 2022, and the remaining seventy-five percent (75%) of the stock options vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on March 1, 2025. /s/ Pramod Gupta 2021-07-12